NeuroOne Medical Technologies (NMTC) Competitors

$4.53 +0.32 (+7.60%)

Closing price 05/18/2026 04:00 PM Eastern

Extended Trading

$4.58 +0.05 (+1.21%)

As of 09:13 AM Eastern

NMTC vs. MBOT, STIM, SNWV, RCEL, and NNOX

Should you buy NeuroOne Medical Technologies stock or one of its competitors? MarketBeat compares NeuroOne Medical Technologies with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with NeuroOne Medical Technologies include Microbot Medical (MBOT), Neuronetics (STIM), Sanuwave Health (SNWV), Avita Medical (RCEL), and Nano-X Imaging (NNOX). These companies are all part of the "medical equipment" industry.

How does NeuroOne Medical Technologies compare to Microbot Medical?

Microbot Medical (NASDAQ:MBOT) and NeuroOne Medical Technologies (NASDAQ:NMTC) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their institutional ownership, media sentiment, risk, earnings, dividends, valuation, profitability and analyst recommendations.

Microbot Medical has a beta of 1.06, meaning that its stock price is 6% more volatile than the broader market. Comparatively, NeuroOne Medical Technologies has a beta of 0.6, meaning that its stock price is 40% less volatile than the broader market.

NeuroOne Medical Technologies has higher revenue and earnings than Microbot Medical. Microbot Medical is trading at a lower price-to-earnings ratio than NeuroOne Medical Technologies, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Microbot Medical	$105K	1,138.61	-$13.14M	-$0.26	N/A
NeuroOne Medical Technologies	$12.10M	3.23	-$3.61M	-$0.85	N/A

In the previous week, Microbot Medical had 8 more articles in the media than NeuroOne Medical Technologies. MarketBeat recorded 10 mentions for Microbot Medical and 2 mentions for NeuroOne Medical Technologies. Microbot Medical's average media sentiment score of 0.74 beat NeuroOne Medical Technologies' score of -0.37 indicating that Microbot Medical is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Microbot Medical	3 Very Positive mention(s)	2 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
NeuroOne Medical Technologies	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Microbot Medical presently has a consensus target price of $7.50, indicating a potential upside of 321.35%. NeuroOne Medical Technologies has a consensus target price of $11.67, indicating a potential upside of 157.54%. Given Microbot Medical's stronger consensus rating and higher possible upside, research analysts clearly believe Microbot Medical is more favorable than NeuroOne Medical Technologies.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Microbot Medical	1 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	1 Strong Buy rating(s)	2.60
NeuroOne Medical Technologies	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.40

16.3% of Microbot Medical shares are held by institutional investors. Comparatively, 16.1% of NeuroOne Medical Technologies shares are held by institutional investors. 4.7% of Microbot Medical shares are held by company insiders. Comparatively, 11.8% of NeuroOne Medical Technologies shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Microbot Medical has a net margin of 0.00% compared to NeuroOne Medical Technologies' net margin of -68.35%. Microbot Medical's return on equity of -21.84% beat NeuroOne Medical Technologies' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Microbot Medical	N/A	-21.84%	-20.71%
NeuroOne Medical Technologies	-68.35%	-98.33%	-69.85%

Summary

Microbot Medical beats NeuroOne Medical Technologies on 12 of the 17 factors compared between the two stocks.

How does NeuroOne Medical Technologies compare to Neuronetics?

Neuronetics (NASDAQ:STIM) and NeuroOne Medical Technologies (NASDAQ:NMTC) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their media sentiment, valuation, institutional ownership, earnings, profitability, risk, analyst recommendations and dividends.

Neuronetics has a beta of 1.13, indicating that its stock price is 13% more volatile than the broader market. Comparatively, NeuroOne Medical Technologies has a beta of 0.6, indicating that its stock price is 40% less volatile than the broader market.

In the previous week, Neuronetics had 1 more articles in the media than NeuroOne Medical Technologies. MarketBeat recorded 3 mentions for Neuronetics and 2 mentions for NeuroOne Medical Technologies. Neuronetics' average media sentiment score of 1.30 beat NeuroOne Medical Technologies' score of -0.37 indicating that Neuronetics is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Neuronetics	1 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
NeuroOne Medical Technologies	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Neuronetics has a net margin of -24.48% compared to NeuroOne Medical Technologies' net margin of -68.35%. NeuroOne Medical Technologies' return on equity of -98.33% beat Neuronetics' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Neuronetics	-24.48%	-139.83%	-27.13%
NeuroOne Medical Technologies	-68.35%	-98.33%	-69.85%

53.6% of Neuronetics shares are owned by institutional investors. Comparatively, 16.1% of NeuroOne Medical Technologies shares are owned by institutional investors. 8.4% of Neuronetics shares are owned by insiders. Comparatively, 11.8% of NeuroOne Medical Technologies shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Neuronetics presently has a consensus price target of $3.00, indicating a potential upside of 154.24%. NeuroOne Medical Technologies has a consensus price target of $11.67, indicating a potential upside of 157.54%. Given NeuroOne Medical Technologies' stronger consensus rating and higher possible upside, analysts clearly believe NeuroOne Medical Technologies is more favorable than Neuronetics.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Neuronetics	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
NeuroOne Medical Technologies	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.40

NeuroOne Medical Technologies has lower revenue, but higher earnings than Neuronetics. NeuroOne Medical Technologies is trading at a lower price-to-earnings ratio than Neuronetics, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Neuronetics	$149.16M	0.55	-$39M	-$0.54	N/A
NeuroOne Medical Technologies	$12.10M	3.23	-$3.61M	-$0.85	N/A

Summary

Neuronetics beats NeuroOne Medical Technologies on 9 of the 16 factors compared between the two stocks.

How does NeuroOne Medical Technologies compare to Sanuwave Health?

Sanuwave Health (NASDAQ:SNWV) and NeuroOne Medical Technologies (NASDAQ:NMTC) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their institutional ownership, earnings, dividends, profitability, risk, valuation, media sentiment and analyst recommendations.

Sanuwave Health has a beta of 1.37, suggesting that its stock price is 37% more volatile than the broader market. Comparatively, NeuroOne Medical Technologies has a beta of 0.6, suggesting that its stock price is 40% less volatile than the broader market.

In the previous week, Sanuwave Health had 7 more articles in the media than NeuroOne Medical Technologies. MarketBeat recorded 9 mentions for Sanuwave Health and 2 mentions for NeuroOne Medical Technologies. Sanuwave Health's average media sentiment score of -0.17 beat NeuroOne Medical Technologies' score of -0.37 indicating that Sanuwave Health is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Sanuwave Health	0 Very Positive mention(s)	2 Positive mention(s)	5 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
NeuroOne Medical Technologies	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Sanuwave Health currently has a consensus target price of $51.00, indicating a potential upside of 202.49%. NeuroOne Medical Technologies has a consensus target price of $11.67, indicating a potential upside of 157.54%. Given Sanuwave Health's stronger consensus rating and higher probable upside, research analysts plainly believe Sanuwave Health is more favorable than NeuroOne Medical Technologies.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Sanuwave Health	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	2.50
NeuroOne Medical Technologies	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.40

Sanuwave Health has a net margin of 35.96% compared to NeuroOne Medical Technologies' net margin of -68.35%. NeuroOne Medical Technologies' return on equity of -98.33% beat Sanuwave Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Sanuwave Health	35.96%	-450.56%	44.87%
NeuroOne Medical Technologies	-68.35%	-98.33%	-69.85%

Sanuwave Health has higher revenue and earnings than NeuroOne Medical Technologies. NeuroOne Medical Technologies is trading at a lower price-to-earnings ratio than Sanuwave Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Sanuwave Health	$44.34M	3.27	$11.81M	$0.33	51.09
NeuroOne Medical Technologies	$12.10M	3.23	-$3.61M	-$0.85	N/A

42.5% of Sanuwave Health shares are owned by institutional investors. Comparatively, 16.1% of NeuroOne Medical Technologies shares are owned by institutional investors. 14.4% of Sanuwave Health shares are owned by company insiders. Comparatively, 11.8% of NeuroOne Medical Technologies shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Summary

Sanuwave Health beats NeuroOne Medical Technologies on 15 of the 17 factors compared between the two stocks.

How does NeuroOne Medical Technologies compare to Avita Medical?

Avita Medical (NASDAQ:RCEL) and NeuroOne Medical Technologies (NASDAQ:NMTC) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their profitability, institutional ownership, media sentiment, dividends, risk, analyst recommendations, earnings and valuation.

Avita Medical currently has a consensus price target of $7.25, indicating a potential upside of 73.03%. NeuroOne Medical Technologies has a consensus price target of $11.67, indicating a potential upside of 157.54%. Given NeuroOne Medical Technologies' stronger consensus rating and higher possible upside, analysts clearly believe NeuroOne Medical Technologies is more favorable than Avita Medical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Avita Medical	1 Sell rating(s)	2 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.33
NeuroOne Medical Technologies	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.40

Avita Medical has a beta of 1.9, indicating that its stock price is 90% more volatile than the broader market. Comparatively, NeuroOne Medical Technologies has a beta of 0.6, indicating that its stock price is 40% less volatile than the broader market.

27.7% of Avita Medical shares are held by institutional investors. Comparatively, 16.1% of NeuroOne Medical Technologies shares are held by institutional investors. 2.8% of Avita Medical shares are held by insiders. Comparatively, 11.8% of NeuroOne Medical Technologies shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

In the previous week, Avita Medical had 9 more articles in the media than NeuroOne Medical Technologies. MarketBeat recorded 11 mentions for Avita Medical and 2 mentions for NeuroOne Medical Technologies. Avita Medical's average media sentiment score of 0.32 beat NeuroOne Medical Technologies' score of -0.37 indicating that Avita Medical is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Avita Medical	0 Very Positive mention(s)	1 Positive mention(s)	7 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
NeuroOne Medical Technologies	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

NeuroOne Medical Technologies has lower revenue, but higher earnings than Avita Medical. NeuroOne Medical Technologies is trading at a lower price-to-earnings ratio than Avita Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Avita Medical	$71.61M	1.80	-$48.59M	-$1.57	N/A
NeuroOne Medical Technologies	$12.10M	3.23	-$3.61M	-$0.85	N/A

Avita Medical has a net margin of -62.67% compared to NeuroOne Medical Technologies' net margin of -68.35%. Avita Medical's return on equity of 0.00% beat NeuroOne Medical Technologies' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Avita Medical	-62.67%	N/A	-76.31%
NeuroOne Medical Technologies	-68.35%	-98.33%	-69.85%

Summary

Avita Medical beats NeuroOne Medical Technologies on 8 of the 15 factors compared between the two stocks.

How does NeuroOne Medical Technologies compare to Nano-X Imaging?

NeuroOne Medical Technologies (NASDAQ:NMTC) and Nano-X Imaging (NASDAQ:NNOX) are both small-cap medical equipment companies, but which is the superior investment? We will compare the two businesses based on the strength of their media sentiment, valuation, earnings, profitability, dividends, risk, analyst recommendations and institutional ownership.

16.1% of NeuroOne Medical Technologies shares are held by institutional investors. Comparatively, 21.5% of Nano-X Imaging shares are held by institutional investors. 11.8% of NeuroOne Medical Technologies shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

In the previous week, Nano-X Imaging had 1 more articles in the media than NeuroOne Medical Technologies. MarketBeat recorded 3 mentions for Nano-X Imaging and 2 mentions for NeuroOne Medical Technologies. Nano-X Imaging's average media sentiment score of 0.32 beat NeuroOne Medical Technologies' score of -0.37 indicating that Nano-X Imaging is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
NeuroOne Medical Technologies	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Nano-X Imaging	0 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

NeuroOne Medical Technologies presently has a consensus target price of $11.67, indicating a potential upside of 157.54%. Nano-X Imaging has a consensus target price of $5.00, indicating a potential upside of 194.12%. Given Nano-X Imaging's stronger consensus rating and higher probable upside, analysts plainly believe Nano-X Imaging is more favorable than NeuroOne Medical Technologies.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
NeuroOne Medical Technologies	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.40
Nano-X Imaging	2 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	3 Strong Buy rating(s)	2.83

NeuroOne Medical Technologies has a beta of 0.6, meaning that its stock price is 40% less volatile than the broader market. Comparatively, Nano-X Imaging has a beta of 1.19, meaning that its stock price is 19% more volatile than the broader market.

NeuroOne Medical Technologies has a net margin of -68.35% compared to Nano-X Imaging's net margin of -790.87%. Nano-X Imaging's return on equity of -64.65% beat NeuroOne Medical Technologies' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
NeuroOne Medical Technologies	-68.35%	-98.33%	-69.85%
Nano-X Imaging	-790.87%	-64.65%	-57.27%

NeuroOne Medical Technologies has higher earnings, but lower revenue than Nano-X Imaging. NeuroOne Medical Technologies is trading at a lower price-to-earnings ratio than Nano-X Imaging, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
NeuroOne Medical Technologies	$12.10M	3.23	-$3.61M	-$0.85	N/A
Nano-X Imaging	$13.02M	9.09	-$75.02M	-$1.59	N/A

Summary

Nano-X Imaging beats NeuroOne Medical Technologies on 12 of the 17 factors compared between the two stocks.

Get NeuroOne Medical Technologies News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding NMTC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

NMTC vs. The Competition

Export

Metric	NeuroOne Medical Technologies	Medical Services Industry	Medical Sector	NASDAQ Exchange
Market Cap	$36.29M	$8.18B	$6.25B	$12.29B
Dividend Yield	N/A	3.06%	2.80%	5.32%
P/E Ratio	-5.33	22.08	20.63	25.23
Price / Sales	3.23	20.96	552.54	79.17
Price / Cash	N/A	12.21	27.48	37.30
Price / Book	5.33	4.84	9.68	6.63
Net Income	-$3.61M	$183.43M	$3.56B	$335.59M
7 Day Performance	3.19%	-1.50%	-1.63%	-1.20%
1 Month Performance	-6.40%	-0.92%	-2.59%	-1.16%
1 Year Performance	14.20%	0.22%	30.08%	28.10%

NeuroOne Medical Technologies Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
NMTC NeuroOne Medical Technologies	4.0092 of 5 stars	$4.53 +7.6%	$11.67 +157.5%	+13.5%	$36.29M	$12.10M	N/A	20	Earnings Report
MBOT Microbot Medical	2.3897 of 5 stars	$2.10 -0.5%	$7.50 +257.1%	-33.6%	$141.70M	N/A	N/A	20	Earnings Report Analyst Upgrade
STIM Neuronetics	3.363 of 5 stars	$2.17 +7.4%	$3.00 +38.2%	-72.0%	$140.55M	$149.16M	N/A	180	Gap Up High Trading Volume
SNWV Sanuwave Health	1.8979 of 5 stars	$15.64 flat	$51.00 +226.1%	-47.8%	$134.48M	$44.05M	N/A	40	Earnings Report
RCEL Avita Medical	3.022 of 5 stars	$4.24 -0.9%	$6.63 +56.3%	-35.1%	$131.72M	$71.61M	N/A	130	Earnings Report Analyst Upgrade

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:NMTC) was last updated on 5/19/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

NeuroOne Medical Technologies (NMTC) Competitors

NMTC vs. MBOT, STIM, SNWV, RCEL, and NNOX

How does NeuroOne Medical Technologies compare to Microbot Medical?

Summary

How does NeuroOne Medical Technologies compare to Neuronetics?

Summary

How does NeuroOne Medical Technologies compare to Sanuwave Health?

Summary

How does NeuroOne Medical Technologies compare to Avita Medical?

Summary

How does NeuroOne Medical Technologies compare to Nano-X Imaging?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

NMTC vs. The Competition

NeuroOne Medical Technologies Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

NeuroOne Medical Technologies (NMTC) Competitors

NMTC vs. MBOT, STIM, SNWV, RCEL, and NNOX

How does NeuroOne Medical Technologies compare to Microbot Medical?

Which has more volatility and risk, MBOT or NMTC?

Which has higher earnings & valuation, MBOT or NMTC?

Does the media favor MBOT or NMTC?

Do analysts recommend MBOT or NMTC?

Do insiders & institutionals have more ownership in MBOT or NMTC?

Is MBOT or NMTC more profitable?

Summary

How does NeuroOne Medical Technologies compare to Neuronetics?

Which has more volatility & risk, STIM or NMTC?

Does the media prefer STIM or NMTC?

Is STIM or NMTC more profitable?

Do insiders and institutionals believe in STIM or NMTC?

Do analysts recommend STIM or NMTC?

Which has better valuation & earnings, STIM or NMTC?

Summary

How does NeuroOne Medical Technologies compare to Sanuwave Health?

Which has more risk and volatility, SNWV or NMTC?

Does the media prefer SNWV or NMTC?

Do analysts recommend SNWV or NMTC?

Is SNWV or NMTC more profitable?

Which has higher earnings and valuation, SNWV or NMTC?

Do insiders & institutionals believe in SNWV or NMTC?

Summary

How does NeuroOne Medical Technologies compare to Avita Medical?

Do analysts rate RCEL or NMTC?

Which has more volatility & risk, RCEL or NMTC?

Do institutionals and insiders believe in RCEL or NMTC?

Does the media favor RCEL or NMTC?

Which has stronger earnings and valuation, RCEL or NMTC?

Is RCEL or NMTC more profitable?

Summary

How does NeuroOne Medical Technologies compare to Nano-X Imaging?

Do institutionals & insiders have more ownership in NMTC or NNOX?

Does the media refer more to NMTC or NNOX?

Do analysts recommend NMTC or NNOX?

Which has more risk & volatility, NMTC or NNOX?

Is NMTC or NNOX more profitable?

Which has higher valuation & earnings, NMTC or NNOX?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

NMTC vs. The Competition

NeuroOne Medical Technologies Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools